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Saudi Journal of Ophthalmology (2012) 26, 241–244Case ReportUnilateral eyelid swelling, proptosis and diplopia as initial manifestation
of acute myeloid leukemiaImtiaz A. Chaudhry, MD, PhD, FACS a,⇑; Ahmad M. Alaraj, MD a; Hind M. Alkatan, MD bAbstractMyeloid sarcoma is a tumor of immature myeloid cells occurring in many extramedullary sites, orbit being one of them where the
tumor may occur prior to or after the diagnosis of underlying disease. We report a case of a 17-year-old male who presented with
upper eyelid swelling, proptosis and diplopia after presumed blunt trauma without any other clinical signs and symptoms. Initial
imaging suggested possibility of subperiosteal hematoma. Magnetic resonance imaging studies demonstrated a solid tumor.
Complete excision of the tumor and histopathologic diagnosis revealed evidence of acute myeloid leukemia (AML). There were
no other sites indicating any tumoral process; however, bone marrow aspirate revealed an evidence of systemic disease. After che-
motherapy and allogenic bone marrow transplant, the patient had complete remission of his disease. An episode of graft vs host
reaction resulting in severe dry eyes along with skin eruptions was treated successfully by immunosuppression and topical lubri-
cation without any visual or systemic sequela. This case emphasizes on the need for an aggressive work-up for any unusual orbital
lesion in the absence of any explainable etiology. Further, AML may be suspected in the cases of orbital tumors even in the
absence of systemic manifestations of leukemia at any age.
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The occurrence of orbital myeloid sarcoma in children and
youth before the development of systemic leukemia may
frequently be confusedwithmalignant tumors such as rhabdo-
myosarcoma, lymphoma and neuroblastoma. In acutemyeloid
leukemia (AML), malignant clones of immature myeloid cells
proliferate replacing the normal bone marrow. These imma-
ture blast cells are released in the blood circulation reaching
distant extramedullary sites including the orbit. Accumulation
of these leukemic cells in the soft tissues or bone is termed as
myeloid sarcoma, an uncommon presentation of AML, which
may occur in 3% of patients having leukemia.1 The accurate
diagnosis of these cases can be challenging, particularly whenPeer review under responsibility
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are not sufficiently specific to distinguish myeloid neoplasm
from other tumors.2,3 We present a case of a 17-year-old male
who was presented with an isolated orbital mass and local
symptoms in the absence of any systemic disease requiring
extensive work-up, treatment of the disease as well as compli-
cations related to the treatment.Case report
A 17-year-male presented with a two month history of
right upper eyelid swelling and gradual proptosis after
a blunt trauma to the right side of his face while playingj Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.comwww.sciencedirect.com
arch 2012; available online 19 March 2012.
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Figure 1. (A) External photograph of a 17-year-male showing right upper eyelid swelling, downward displacement of his right eye globe and proptosis.
(B and C) Computed tomography scan (coronal and sagittal views) and (D and E) magnetic resonance imaging (coronals T1WI and T2WI) demonstrate an
evidence of a uniform, well-demarcated lesion occupying the superior orbit and compressing the globe downward and outward.
Figure 3. External photograph of the same patient 6 months following
successful induction and allogenic stem cell transplant showing evidence
of graft vs host reaction and dry eye syndrome. There was no evidence of
right upper eyelid swelling or proptosis.
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on up-gaze (Fig. 1A). He was evaluated by local health care
facility and diagnosis of subperiosteal hematoma was made
based on computed tomographic (CT) scan (Fig. 1B, coronal
view; C, sagittal view) and referred for further treatment. On
examination, his vision was 20/20 in both eyes along with nor-
mal intraocular pressures. There was no relative afferent pap-
illary defect; however, there was limitation of right eye
movement on upward gaze. There was no palpable lymphad-
enopathy and his neurological examination was normal. Mag-
netic resonance imaging (MRI, Fig. 1D, T1WI; E, T2WI) and
CT scan revealed an evidence of a uniform, well-demarcated
lesion occupying the superior orbit and compressing the
globe downward. His hemoglobin, total leukocyte count
along with differential leukocytic count showed normal neu-
trophils, lymphocytes and reticulocytes. Through the right
upper eyelid crease incision, a large tumor which was adher-
ent to the local tissue was removed piece by piece. Grossly,
the specimen consisted of multiple yellowish soft tissue
pieces which aggregated to measure 32  26  8 mm
(Fig. 2A). The pieces were serially sectioned and subjected
to microscopic study after staining. The histologic sections
showed diffused sheets of proliferating large cells with vesic-
ular nuclei and small prominent nucleoli. The proliferating
cells infiltrated the orbital soft tissue and fat. In some areas,
the collection of mature lymphocytes with the formation of
few lymphoid follicles was also observed. Some of theFigure 2. (A) Photograph of the gross specimen showing multiple yellowish so
with the formation of lymphoid follicles and scattered plasma cells (hematox
staining showing that the proliferating large cells were diffusely positive for mlymphoid follicles showed well-defined germinal centers
(Fig. 2B). Scattered plasma cells were also seen among these
cells. The immunohistochemical staining showed that theft tissue pieces. (B) The histologic sections showing proliferating large cells
ylin and eosin original magnification 50). (C) The immunohistochemical
yeloperoxidase stain (magnification 200).
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oxidase stain and scattered lymphocytes were positive for
CD3 (Fig. 2C). The overall histopathologic appearance and
the immunohistochemical staining were consistent with the
diagnosis of extramedullary leukemia (myeloid sarcoma).
His bone marrow aspirate biopsy showed hypercellular mar-
row smears with the proliferation of blast cells which were
positive for myeloperoxidase. Following diagnosis, the pa-
tient underwent induction treatment followed by allogenic
stem cell transplantation. Six months later, the patient had
mucosal and skin eruption of his body requiring immunosup-
pression after the diagnosis of graft vs host reaction was con-
firmed following a biopsy of these lesions (Fig. 3). His ocular
symptoms included severe dry eyes which were treated by
immunosuppressives and topical lubrication. At 10 months
of follow-up, the patient remained symptoms free with nor-
mal vision and absence of diplopia.Discussion
Orbital involvement as an initial manifestation of AML is
less common. Most cases present with unilateral proptosis
and only few case reports have documented bilateral orbital
involvement as initial manifestation of AML.2,4–6 The patient
may present with painful proptosis and limitation of ocular
motility. Orbital leukemic tumors occur most commonly in
the first decade of life, in association with AML. Zimmerman
and Font7 reported on their clinicopathologic review of 33
well-documented cases of myeloid sarcoma on a file in the
Registry of Ophthalmic Pathology and confirmed the facts
that the tumor was encountered mainly in children and that
the boys were affected more frequently than girls. Their re-
view suggested that the tumor may appear before, after, or
concomitantly with hematologic evidence of leukemia. In
their series of 33 cases, only four patients were already
known to have leukemia when they were first seen by an oph-
thalmologist for their orbital, ocular, or adnexal lesions.7
Clinical and imaging features of orbital leukemic tumors
have been characterized by Bidar et al., 2007, in their 27 pa-
tients with a diagnosis of orbital AML.8 The median age at
the diagnosis of orbital leukemic tumor in their study was
8 years (range, 1–18 years). Nineteen of their 27 patients
were male and 21 patients had AML, five had acute lympho-
blastic leukemia (ALL), and one had chronic myelogenous
leukemia. In their 23 (85%) patients, the diagnosis of leuke-
mia was based on the bone marrow examination findings.
Nine patients had bilateral orbital involvement and proptosis.
The proptosis may be mainly due to leukemic infiltration of
the orbit and has been found to be present in over 9% cases
of AML.9 Some of the other manifestations of the orbital infil-
tration with AML may include ptosis, lacrimal gland enlarge-
ment, conjunctival mass and even uveal infiltration.1,10 As
presented in our case, diplopia along with local swelling
may be the initial presentation in some patients with AML,
concurrent history of trauma may delay early medical consul-
tation and treatment. On imaging studies such as CT scan,
the orbital extramedullary leukemic mass may demonstrate
a well-defined homogenous mass lesion which may be iso-
dense to the surrounding muscles.11 The mass may enhance
with contrast application. These homogenous lesions mold
to one or more orbital walls without any bony destruction,as apparent from the patient presented in this report
(Fig. 1). On MRI, the lesion may appear isointense on T1-
weighted and hyperintense on T2-weighted images, while it
may enhance intensely with contrast administration.10–12
Peripheral blood smear is helpful in diagnosing the sys-
temic form of AML, revealing immature blast cells with a high
total leukocyte count and relative neutropenia. As our patient
demonstrated, leukemic proptosis, however, may not always
be associated with leukocytosis or immature cells in the
peripheral blood smear. Biopsy of the orbital lesion along
with bone marrow aspirate was necessary to confirm the
diagnosis of AML in our patient. Further, immunohistochem-
istry and immunocytochemistry may be required to detect
the antibody against myeloperoxidase (Fig. 2). Murthy et
al.13 have highlighted the orbital manifestations of AML
and the role of peripheral blood smear in the diagnosis of
their patients who presented with proptosis and were subse-
quently diagnosed to have AML based on peripheral blood
smears or incisional biopsy. The median age at the presenta-
tion of their 12 patients was 6 years and none of these pa-
tients had been diagnosed earlier as having AML. The
presenting features included proptosis, visual symptoms
and subconjunctival hemorrhage. A diagnosis of AML was
made by incisional biopsy in four patients and by peripheral
blood smear examination in eight patients.13 Rénard et al.14
reported three cases of pediatric myeloid sarcomas with var-
ious locations, orbit being one of them. In all of their three
cases, the diagnosis was also delayed or initially missed.
Chemotherapy is the mainstay of treatment in cases of
AML, the protocols however are not standardized.10,11 Che-
motherapy includes both intensive and consolidation phases.
In the intensive phase, the drugs doxorubicin and cytosine
arabinoside are used. Growth factors help in stimulating
bone marrow following the intensive phase of chemotherapy.
The presence of extramedullary leukemia may not alter the
survival of patients with AML. Despite the advances in che-
motherapeutic regimens, an allogenic bone marrow trans-
plantation from a matched family donor still remains the
best long-term option that may provide a remission-free sur-
vival for most patients.15 Although the overall survival rate for
patients with leukemia has improved over the past several
decades, the mortality of the patients who develop orbital
leukemic tumors remains high. In Bidar et al.,8 series of 27 pa-
tients, all of their patients received multi-agent systemic che-
motherapy, and 14 underwent bone marrow transplantation.
Five patients received external beam radiation for the treat-
ment of orbital disease. The median survival for all of their pa-
tients was 4.75 years (range, 0.1–24 years) after the diagnosis
of orbital disease.
Lesions associated with leukemia have been classified as
specific (due to leukemic infiltration of various ocular tissues),
nonspecific (due to one of the secondary complications), or
iatrogenic manifestations caused by chemotherapy. Russo
et al.16 evaluated orbital and ocular manifestations of their
patients with acute childhood leukemia according to an as-
signed risk-based treatment depending on the clinical and
laboratory features at diagnosis. They noted specific lesions
in 66% of their 180 patients with AML which were more se-
vere in high risk leukemia patients than in patients with stan-
dard risk leukemia. Orbital or ocular lesions were noted more
commonly in patients with AML (66.6%) compared to pa-
tients with ALL (15.1%). In both the AML and ALL groups,
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bone marrow and/or CNS in patients with specific lesions
(63.1%) compared to patients with nonspecific lesions
(42%), and in patients without orbital or ocular lesions
(29.2%). Children presenting with white blood cell count be-
low 50,000 mm3 were considered at standard risk for treat-
ment failure, while all others were considered at high risk
for treatment failure. In their study, the presence of specific
orbital or ocular lesions was associated with a higher fre-
quency of bone marrow relapse and CNS involvement.
Various chemotherapeutic agents used to treat leukemia
may cause ocular toxicity. Bone marrow transplants have
been found to be very successful in prolonging patient sur-
vival in many patients. As our case suggests, there is an obvi-
ous risk of graft vs host rejection from inflammatory infiltrates
of many organs that may result in severe dry eyes due to lac-
rimal glands infiltration and hence alacrima. Further, immuno-
compromised patients may be at additional risk of eye and
other organ infections both from AML and due to associated
treatment interventions. It is imperative that ophthalmolo-
gists should be aware of the complications of disease and
associated side effects of the treatment of leukemia for their
early recognition and treatment.17
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